Your browser doesn't support javascript.
loading
Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.
Vögtle, Timo; Sharma, Sumana; Mori, Jun; Nagy, Zoltan; Semeniak, Daniela; Scandola, Cyril; Geer, Mitchell J; Smith, Christopher W; Lane, Jordan; Pollack, Scott; Lassila, Riitta; Jouppila, Annukka; Barr, Alastair J; Ogg, Derek J; Howard, Tina D; McMiken, Helen J; Warwicker, Juli; Geh, Catherine; Rowlinson, Rachel; Abbott, W Mark; Eckly, Anita; Schulze, Harald; Wright, Gavin J; Mazharian, Alexandra; Fütterer, Klaus; Rajesh, Sundaresan; Douglas, Michael R; Senis, Yotis A.
Afiliação
  • Vögtle T; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Sharma S; Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Mori J; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Nagy Z; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Semeniak D; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
  • Scandola C; Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
  • Geer MJ; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Smith CW; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Lane J; Sygnature Discovery Limited, Nottingham, United Kingdom.
  • Pollack S; Sygnature Discovery Limited, Nottingham, United Kingdom.
  • Lassila R; Coagulation Disorders Unit, Department of Hematology, Comprehensive Cancer Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Jouppila A; Aplagon Oy, Helsinki, Finland.
  • Barr AJ; Coagulation Disorders Unit, Helsinki University Hospital Research Institute, Helsinki, Finland.
  • Ogg DJ; Department of Biomedical Science, Faculty of Science & Technology, University of Westminster, London, United Kingdom.
  • Howard TD; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • McMiken HJ; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Warwicker J; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Geh C; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Rowlinson R; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Abbott WM; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Eckly A; Peak Proteins Limited, Alderley Park, Cheshire, United Kingdom.
  • Schulze H; Université de Strasbourg, Institut National de la Santé et de la Recherche Médicale, Etablissement Français du Sang Grand Est, Unité Mixte de Recherche-S 1255, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
  • Wright GJ; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
  • Mazharian A; Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
  • Fütterer K; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Rajesh S; School of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Douglas MR; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Senis YA; Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Elife ; 82019 08 22.
Article em En | MEDLINE | ID: mdl-31436532

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Megacariócitos / Receptores Imunológicos / Heparitina Sulfato Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Megacariócitos / Receptores Imunológicos / Heparitina Sulfato Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Elife Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido